Gene · 5582
Papers1,943
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,943
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. | J Transl Med | 2022 | 36528667 | PubTator, text mining | PubMed |
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| Predicting chemical structure using reinforcement learning with a stack-augmented conditional variational autoencoder. | J Cheminform | 2022 | 36494855 | PubTator, text mining | PubMed |
| Analyzing PKC Gamma (+ 19,506 A/G) polymorphism as a promising genetic marker for HCV-induced hepatocellular carcinoma. | Biomark Res | 2022 | 36451234 | PubTator, text mining | PubMed |
| Spatiotemporal control of necroptotic cell death and plasma membrane recruitment using engineered MLKL domains. | Cell Death Discov | 2022 | 36446770 | PubTator, text mining | PubMed |
| Integrated bioinformatics-based identification of diagnostic markers in Alzheimer disease. | Front Aging Neurosci | 2022 | 36437991 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates. | Cancers (Basel) | 2022 | 36428765 | PubTator, text mining | PubMed |
| A Novel Immune-Related Gene Prognostic Index (IRGPI) in Pancreatic Adenocarcinoma (PAAD) and Its Implications in the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36428747 | PubTator, text mining | PubMed |
| Natural Products Targeting Hsp90 for a Concurrent Strategy in Glioblastoma and Neurodegeneration. | Metabolites | 2022 | 36422293 | PubTator, text mining | PubMed |
| Downregulation of protein kinase C gamma reduces epithelial property and enhances malignant phenotypes in colorectal cancer cells. | iScience | 2022 | 36404918 | PubTator, text mining | PubMed |
Dynamic Long-Range Interactions Influence Substrate Binding and Catalysis by Human Histidine Triad Nucleotide-Binding Proteins (HINTs), Key Regulators of Multiple Cellular Processes and Activators of Antiviral ProTides. | Biochemistry | 2022 | 36398895 | PubTator, text mining | PubMed |
| Molecular basis of the PIP2-dependent regulation of CaV2.2 channel and its modulation by CaV β subunits. | Elife | 2022 | 36374183 | PubTator, text mining | PubMed |
| The metabolomics of a protein kinase C delta (PKCδ) knock-out mouse model. | Metabolomics | 2022 | 36371785 | PubTator, text mining | PubMed |
| Transcriptomic Studies of Antidepressant Action in Rodent Models of Depression: A First Meta-Analysis. | Int J Mol Sci | 2022 | 36362329 | PubTator, text mining | PubMed |
| Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer. | Cancers (Basel) | 2022 | 36358843 | PubTator, text mining | PubMed |
| Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness. | Cancers (Basel) | 2022 | 36358747 | PubTator, text mining | PubMed |
| Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells. | Cancers (Basel) | 2022 | 36358633 | PubTator, text mining | PubMed |
| Network Pharmacology- and Molecular Dynamics Simulation-Based Bioprospection of Aspalathus linearis for Type-2 Diabetes Care. | Metabolites | 2022 | 36355096 | PubTator, text mining | PubMed |
Quantification of promoting efficiency and reducing toxicity of Traditional Chinese Medicine: A case study of the combination of Tripterygium wilfordii hook. f. and Lysimachia christinae hance in the treatment of lung cancer. | Front Pharmacol | 2022 | 36339610 | PubTator, text mining | PubMed |
| PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer. | Front Endocrinol (Lausanne) | 2022 | 36329884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5582/papers?page=12